The Compound Of Formula I And Composition Comprising The Same

Abstract: The invention relates to the compounds or its pharmaceutical acceptable polymorphs solvates enantiomers stereoisomers and hydrates thereof. The pharmaceutical compositions comprising an effective amount of compounds of formula I formula II formula III formula IV formula V formula VI formula VII formula VIII formula IX or Formula X and the methods for the treatment of fungal infections may be formulated for oral buccal rectal topical transdermal transmucosal lozenge spray intravenous oral solution buccal mucosal layer tablet parenteral administration syrup or injection. Such compositions may be used to treatment of fungal infections.

Patent Information

Application #

Filing Date

28 May 2019

Publication Number

29/2019

Publication Type

INA

Invention Field

CHEMICAL

Status

Email

tarun@khuranaandkhurana.com

Parent Application

Patent Number

Legal Status

Grant Date

2021-10-29

Renewal Date

Applicants

CELLIX BIO PRIVATE LIMITED

Plot No. 1177 B, Road No. 56, Jubilee Hills Hyderabad, Andhra Pradesh 500033.

Inventors

1. KANDULA, Mahesh

Door No: 11-61, G. Medapadu, Samalkot Mandal East Godavari District, Andhra Pradesh 533434.

Specification

SOFT COPY ATTACHED IN PDF

Documents

Application Documents

#	Name	Date
1	201947021083-STATEMENT OF UNDERTAKING (FORM 3) [28-05-2019(online)].pdf	2019-05-28
2	201947021083-PROOF OF RIGHT [28-05-2019(online)].pdf	2019-05-28
3	201947021083-PRIORITY DOCUMENTS [28-05-2019(online)].pdf	2019-05-28
4	201947021083-POWER OF AUTHORITY [28-05-2019(online)].pdf	2019-05-28
5	201947021083-FORM-9 [28-05-2019(online)].pdf	2019-05-28
6	201947021083-FORM FOR SMALL ENTITY(FORM-28) [28-05-2019(online)].pdf	2019-05-28
7	201947021083-FORM 1 [28-05-2019(online)].pdf	2019-05-28
8	201947021083-EVIDENCE FOR REGISTRATION UNDER SSI(FORM-28) [28-05-2019(online)].pdf	2019-05-28
9	201947021083-DRAWINGS [28-05-2019(online)].pdf	2019-05-28
10	201947021083-DECLARATION OF INVENTORSHIP (FORM 5) [28-05-2019(online)].pdf	2019-05-28
11	201947021083-COMPLETE SPECIFICATION [28-05-2019(online)].pdf	2019-05-28
12	201947021083-CLAIMS UNDER RULE 1 (PROVISIO) OF RULE 20 [28-05-2019(online)].pdf	2019-05-28
13	201947021083.pdf	2019-06-05
14	201947021083-FORM 3 [25-09-2019(online)].pdf	2019-09-25
15	201947021083-OTHERS [04-11-2020(online)].pdf	2020-11-04
16	201947021083-FORM FOR STARTUP [04-11-2020(online)].pdf	2020-11-04
17	201947021083-FORM FOR SMALL ENTITY [04-11-2020(online)].pdf	2020-11-04
18	201947021083-FORM 18 [14-11-2020(online)].pdf	2020-11-14
19	201947021083-RELEVANT DOCUMENTS [10-07-2021(online)].pdf	2021-07-10
20	201947021083-POA [10-07-2021(online)].pdf	2021-07-10
21	201947021083-FORM 13 [10-07-2021(online)].pdf	2021-07-10
22	201947021083-PETITION UNDER RULE 137 [31-07-2021(online)].pdf	2021-07-31
23	201947021083-OTHERS [31-07-2021(online)].pdf	2021-07-31
24	201947021083-Information under section 8(2) [31-07-2021(online)].pdf	2021-07-31
25	201947021083-FORM 3 [31-07-2021(online)].pdf	2021-07-31
26	201947021083-FER_SER_REPLY [31-07-2021(online)].pdf	2021-07-31
27	201947021083-DRAWING [31-07-2021(online)].pdf	2021-07-31
28	201947021083-CORRESPONDENCE [31-07-2021(online)].pdf	2021-07-31
29	201947021083-COMPLETE SPECIFICATION [31-07-2021(online)].pdf	2021-07-31
30	201947021083-CLAIMS [31-07-2021(online)].pdf	2021-07-31
31	201947021083-Correspondence to notify the Controller [19-08-2021(online)].pdf	2021-08-19
32	201947021083-Written submissions and relevant documents [07-09-2021(online)].pdf	2021-09-07
33	201947021083-Annexure [07-09-2021(online)].pdf	2021-09-07
34	201947021083-US(14)-HearingNotice-(HearingDate-23-08-2021).pdf	2021-10-18
35	201947021083-FER.pdf	2021-10-18
36	201947021083-PatentCertificate29-10-2021.pdf	2021-10-29
37	201947021083-IntimationOfGrant29-10-2021.pdf	2021-10-29

Search Strategy

1	SS201947021083E_25-01-2021.pdf